Feed WANBURY.NS
WA

Wanbury Limited

WANBURY.NS · NSE

₹194.99 -1.87% (-₹3.71)
1M -19.78%
Market Cap ₹7.03B
P/E Ratio 12.59x
Div. Yield -
ROE 53.46%

Bulios Fair Price

₹112.15

42.5% downside

Current Price

₹194.99

Undervalued Fair Value Overvalued

According to Bulios Fair Price, WANBURY.NS is currently overvalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Weak
2/9
Valuation
83 /100
Cheap
P/E 12.59x
EV/EBITDA 9.63x
P/S 1.08x
Growth
64 /100
Stable
Rev. growth 9.29%
EPS growth N/A
FCF growth N/A
Profitability
44 /100
Moderate
Gross margin 40.54%
Net margin 8.56%
Op. margin 12.85%
Quality
99 /100
Excellent
ROIC 23.56%
ROE 53.46%
ROA 10.80%
Debt
43 /100
Moderate
Debt/Equity 1.55x
Current ratio 1.19x
Int. coverage 2.66x
Stability
52 /100
Moderate
Beta 1.26x
Rev. volatility 5.54%
EPS volatility 353.87%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about WANBURY.NS
Online

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Pradeep Patni

Employees

1,200

Headquarters

Navi Mumbai

Upcoming events

12 NOV

Earnings

Upcoming earnings report

35d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.